Hyperthyroidism
Studies in the area of hyperthyroidism reported from University Hospital
Published in Women's Health Weekly, November 18th, 2010
Investigators publish new data in the report 'Treatment of Graves' hyperthyroidism with thionamides-derived drugs: review.' "Thionamide-derived antithyroid drugs (ATD) have been in use for over half a century and much is now known about their mechanism of action, pharmacokinetics and clinical pharmacology. Candidates for first option ATD therapy are young adults, without large goitre," researchers in Vigo, Spain report.
"The recommended initial dose for patients without big goitre and mild hyperthyroidism is 20 mg of MMI/CBZ. The recommended maintenance doses are 5-10 mg of MMI/CBZ. In cases of big goitre and/or severe hyperthyroidism the recommended initial dose is 30...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
CyberKnife Radiosurgery for Early-Stage Breast Cancer - Cervical Cancer
Data from A. Martinez et al provide new insights into cervical cancer - Breast Cancer
Data from University of Nottingham provide new insights into breast cancer - Breast Cancer
Data from University of Texas provide new insights into breast cancer - Ductal Carcinoma
Data on ductal carcinoma discussed by researchers at Soochow University, Department of Pathology - Breast Cancer
Evonail and Evodry Gaining Wide Acceptance at Breast Cancer Awareness Campaigns Amongst Patients Looking to Improve Quality of Life - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
